Close Menu

NEW YORK (GenomeWeb) – Biodesix said today BlueCross BlueShield (BCBS) of Florida and Health Care Services Corporation (HCSC) have agreed to cover its Veristrat lung cancer test.

BCBS of Florida covers four million people in that state and began covering Veristrat effective March 15 of this year. HCSC, which will begin covering Veristrat on June 1, has over 15 million members in states including Illinois, Montana, New Mexico, Oklahoma, and Texas.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.